El interés en corto de NewAmsterdam Pharma da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de NewAmsterdam Pharma. Los datos de interés en corto se actualizan cada dos semanas.

NewAmsterdam Pharma (NASDAQ:NAMS) Bolsa, Informe de interés en corto

NewAmsterdam Pharma

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co NV

NewAmsterdam Pharma Company N.V. - Warrant

NamSys Inc

Earnings

ACRE

AEIS

AEMD

ALCO

ALKS

AMWL

ASND

ASPN

ATRC

AVXL

AYTU

BIIB

BROS

BXMT

CAMT

CGNX

CHEF

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) will release its fourth-quarter financial results, before the opening bell, <a href="https://www.benzinga.com/quote/biib/earnings">on Wednesday, Feb. 12, 2025.</a>
Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $3.36 per share, up from $2.95 per share in the year-ago period. Biogen projects quarterly revenue of $2.42 billion, compared to $2.39 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sage Therapeutics recently announced that its Board of Directors initiated a process to explore strategic alternatives and rejected the unsolicited, nonbinding proposal it received from Biogen for $7.22 per share.
Biogen shares fell 2.2% to close at $139.39 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BIIB/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Geoff Meacham maintained a Neutral rating and cut the price target from $190 to $160 on Jan. 28, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and slashed the price target from $190 to $165 on Jan. 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>BMO Capital analyst Evan Seigerman downgraded the stock from Outperform to Market Perform and cut the price target from $230 to $164 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Needham analyst Ami Fadia downgraded the stock from Buy to Hold with a price target of $270 on Nov. 18, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Oppenheimer analyst Jay Olson maintained an Outperform rating and cut the price target from $270 to $255 on Oct. 31, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying BIIB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png" alt="" class="wp-image-778054" style="width:505px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

California-based EV startup Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) on Tuesday released a series of teaser images, accompanied by the message &#8220;a mirage takes shape Feb 19.&#8221;
What Happened: The teaser images feature tire marks on the sand and also an image of the underside of a vehicle. One of the pictures shows sand dunes as seen through the R1T&#8217;s gear tunnel.
&#8220;Let the countdown begin!,&#8221; Rivian said in a post reply on X. 
The cryptic images shared on email, as well as social media platform X, have customers guessing.
While some are predicting a sand color exterior, others expect an imminent launch of the R2T, a pickup truck variant of the company&#8217;s upcoming R2 vehicle. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R2T?
&mdash; Ethan (@EZebroni) <a href="https://twitter.com/EZebroni/status/1889386475634008486?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Yet another expects a launch for R1X, a rumored rugged variant of the company&#8217;s R1 vehicles.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R1X! The ruggedized version of the R1T. Longer suspension travel, reinforced bumpers and undercarriage. Built in winch. Quad motor with new types of lockers to mimic mechanical lockers.
&mdash; adjust.clinic (@LloydChiro) <a href="https://twitter.com/LloydChiro/status/1889385119276052533?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Popular tech YouTuber Marques Brownlee joined the guessing game and responded to the images with a short, &#8220;R2D2?&#8221; It is unclear what Brownlee intended with the response. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R2D2?
&mdash; Marques Brownlee (@MKBHD) <a href="https://twitter.com/MKBHD/status/1889392266445467755?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Rivian currently has only two vehicle models for individual customers- the R1T truck and the R1S SUV, both priced over $70,000 in the U.S. 
However, the company is looking to <a href="https://www.benzinga.com/25/01/43214741/rivian-ceo-warns-legacy-automakers-against-underinvesting-in-evs-in-light-of-policy-shift-big-miscalculation-for-long-term">expand its total addressable market</a> with the R2 SUV expected to be priced around $45,000, in the same price range as Tesla&#8217;s best-selling Model Y SUV. R2 is expected to enter production in early 2026.
The company is also planning to start deliveries of its&nbsp;<a href="https://www.benzinga.com/news/24/03/37552684/rivian-almost-catches-up-to-teslas-ev-lineup-with-new-r2-r3-but-theres-no-cybertruck-fighter-yet" target="_blank" rel="noreferrer noopener">R3 crossover after the R2.</a>&nbsp;The crossover is expected to be priced lower than the R2 SUV but it is unclear whether the R3&#8217;s price will undercut the Tesla Model 3 or remain within the same range. The company unveiled the R3X, a performance variant of the R3, last year when it unveiled the R2 SUV. 
Rivian is slated to report its fourth-quarter results on Feb. 20 at 2 pm PT.
For the full year 2024, Rivian&nbsp;<a href="https://www.benzinga.com/tech/25/01/42807694/rivian-reports-2nd-highest-quarterly-ev-deliveries-as-2024-wraps-up" target="_blank" rel="noreferrer noopener">delivered 51,579 EVs</a>, within its guidance of 50,500 to 52,000 deliveries.
In the three months through the end of December, the company delivered 14,183 vehicles, its second-highest quarterly delivery numbers since it started deliveries in 2021. &nbsp;
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/02/43647669/tesla-releases-supervised-full-self-driving-in-mexico-says-hola-to-local-drivers">Tesla Releases Supervised Full Self-Driving In Mexico, Says &#8216;Hola&#8217; To Local Drivers</a></li>
</ul>
Image Courtesy of Rivian Automotive

Tech

RIVN

MKBHD Joins Guessing Game After Rivian Teases 'Mirage' Event For Feb. 19: What's Going On?

Mowi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MHGVY#OTC">MHGVY</a>) reported quarterly earnings of $0.33 per share. This is a 17.86 percent increase over earnings of $0.28 per share from the same period last year. The company reported $1.60 billion in sales this quarter. This is a 4.30 percent increase over sales of $1.53 billion the same period last year.

MHGVY

Mowi Q4 EPS Adj. $0.33 Up From $0.28 YoY, Sales $1.60B Up From $1.53B YoY

Sysmex (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSMXY#OTC">SSMXY</a>) reported quarterly earnings of $0.09 per share. This is a 33.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported $816.73 million in sales this quarter. This is a 6.00 percent increase over sales of $770.50 million the same period last year.

SSMXY

Sysmex Q3 EPS $0.09 Down From $0.13 YoY, Sales $816.73M Up From $770.50M YoY

Allianz Chief Economic Advisor Mohamed El-Erian warned that while President Donald Trump&#8216;s evolving tariff strategy may deliver immediate gains, it risks longer-term economic damage through stagflation and eroded U.S. global influence.
What Happened: El-Erian explained on X that the Trump administration&#8217;s tariff strategy follows a three-pronged approach, as highlighted in a Bloomberg Opinion <a href="https://www.bloomberg.com/opinion/articles/2025-02-11/trump-s-early-tariff-wins-mask-future-risks">piece</a> Tuesday: broad duties for revenue and trade balance, targeted protection for industries like steel and aluminum, and strategic tariff threats for political leverage.
&#8220;America&#8217;s many structural advantages and its bigger and cyclically stronger economy give it the upper hand in most negotiations,&#8221; El-Erian wrote, citing recent success in trade disputes with Colombia. However, he cautioned that &#8220;uncertainty is a feature rather than a bug&#8221; in the current approach.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Posted earlier today: Some thoughts on the evolution of US tariff policy:<a href="https://t.co/pQ3wJWLaBU">https://t.co/pQ3wJWLaBU</a><a href="https://twitter.com/opinion?ref_src=twsrc%5Etfw">@opinion</a> <a href="https://twitter.com/hashtag/markets?src=hash&amp;ref_src=twsrc%5Etfw">#markets</a> <a href="https://twitter.com/hashtag/trade?src=hash&amp;ref_src=twsrc%5Etfw">#trade</a> <a href="https://twitter.com/hashtag/tariffs?src=hash&amp;ref_src=twsrc%5Etfw">#tariffs</a> <a href="https://twitter.com/hashtag/economy?src=hash&amp;ref_src=twsrc%5Etfw">#economy</a> <a href="https://t.co/Ovnr5WVSYD">pic.twitter.com/Ovnr5WVSYD</a>
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1889340333189746843?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The warning comes as Trump pledged to <a href="https://in.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">impose 25% tariffs</a> on metal imports without exemptions, sending U.S. steel stocks like Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) and Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) soaring on Monday.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a>
Why It Matters: Former Treasury Secretary Larry Summers echoed these concerns, <a href="https://in.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">stating on social media </a>that the proposed tariffs would lead to &#8220;fewer American jobs, more American inflation, and probably a bigger trade deficit.&#8221;
El-Erian highlighted particular risks for low-income consumers and companies still recovering from post-pandemic inflation. He argued that frequent use of tariffs could make America &#8220;a less reliable partner,&#8221; potentially reducing bilateral trade interactions.
&#8220;Trade is an intrinsically cooperative game,&#8221; El-Erian noted. &#8220;Playing it uncooperatively can benefit the more powerful party in the short term&#8230; But the longer that international trade is played as an uncooperative game, the bigger the welfare losses to everyone participating, including the U.S.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43646173/bitcoin-ethereum-dogecoin-dip-even-as-fed-chair-powell-says-no-to-cbdcs-analyst-says-btc-under-consolidation-but-next-big-move-could-be-likely">Bitcoin, Ethereum, Dogecoin Dip Even As Fed Chair Powell Says No To CBDC: Analyst Says BTC Under Consolidation But &#8216;Next Big Move&#8217; Likely</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

Mohamed El-Erian Says Trump's 'Uncooperative' Tariff Play Can Benefit America, But Could Lead To 'Welfare Losses' In Long-Term

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) researcher Troy Teslike expects the company&#8217;s EV deliveries in the first quarter to fall below 400,000 units. The EV giant&#8217;s quarterly deliveries have not fallen below 400,000 since the third quarter of 2022. 
What Happened: As per Teslike, who tracks Tesla delivery and production numbers, vehicle deliveries may be negatively impacted by limitations in ramping the production of the refreshed Model Y vehicle, poor brand sentiment, and the seasonal nature of vehicle demand. 
However, vehicle deliveries in the quarter could also be positively impacted by the launch of the new Model Y, the researcher noted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hi everyone. I expect Tesla deliveries this quarter to be below 400,000 units. There are four negative and one positive factor affecting deliveries: <a href="https://t.co/JU72e9NBy0">https://t.co/JU72e9NBy0</a> • Negative: Model Y Juniper production limitations • Negative: Seasonality • Negative: Demand pulled…
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1889349816880165271?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
For the full year 2025, Teslike expects deliveries to be <a href="https://www.benzinga.com/25/01/43375903/tesla-researcher-estimates-drop-in-ev-deliveries-for-2025-despite-promise-of-new-models">below the numbers reported in 2024</a>. Tesla reported global&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a>&nbsp;vehicles in 2024, down from full-year deliveries of 1.81 million in 2023, marking the first decline in over a decade.
Tesla CEO Elon Musk said in October that he expects a 20-30% increase in deliveries in 2025. However, the CEO didn&#8217;t reiterate the target during the company&#8217;s fourth-quarter earnings in January. Instead, Tesla only said that it expects the vehicle business to &#8220;return to growth&#8221; in 2025. 
&#8220;I interpret this to mean Tesla's target is 1,790,000 units. This looks difficult to me. My estimate is lower,&#8221; Teslike said on Tuesday. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon previously mentioned 20-30% growth, but since he didn't repeat this in the last earnings call, it's no longer considered a target. Instead, Tesla said this: Tesla: &quot;We expect the vehicle business to return to growth in 2025&quot; Source (page 12): <a href="https://t.co/jWK71ucc02">https://t.co/jWK71ucc02</a> With…
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1889351313273614643?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Tesla launched the refreshed version of Model Y, its best-selling vehicle, in January. 
The company commenced production of the refreshed vehicle less than two weeks ago across its four vehicle factories around the world in Califonia, Texas, Shanghai, and Berlin. Deliveries of the vehicle are slated to start in March.
Musk&nbsp;said during the company's earnings call last month that the company will&nbsp;<a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1" target="_blank" rel="noreferrer noopener">lose production in the days of retooling&nbsp;</a>factories to prepare for production of the refreshed vehicle. The CEO also warned that margins will be impacted due to idle capacity and other ramp-related costs. However, these challenges will be overcome once production is ramped, he said.
Tesla last reported quarterly deliveries below 400,000 units <a href="https://www.benzinga.com/general/education/24/10/41166723/how-many-evs-has-tesla-delivered-produced-each-quarter-a-look-at-the-results-since-2019">in the third quarter of 2022</a>. The company delivered just 365,923 vehicles in that quarter. 
In the last quarter of 2024, Tesla reported 495,570 deliveries after resorting to offers and discounts across geographies. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43614443/tesla-starts-production-at-shanghai-megafactory-in-less-than-9-months-of-beginning-construction">Tesla Starts Production At Shanghai Megafactory Less Than 9 Months After Beginning Construction</a></li>
</ul>
Image via Shutterstock

Analyst Color

TSLA

Tesla Q1 Deliveries Could Drop Below 400,000 As Brand Sentiment Takes A Hit, Says Researcher

2025 outlook: underlying operating margin of around 4%; mid- to high-single-digit underlying EPS growth; free cash flow of at least €2.2 billion; and gross capital expenditures of around €2.7 billion

Guidance

ADRNY

Koninklijke Ahold Delhaize Forecasts 2025 Outlook: ~4% Operating Margin, Mid- To High-Single-Digit EPS Growth, €2.2B+ Free Cash Flow, And €2.7B in Capital Expenditures

Koninklijke Ahold Delhaiz (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADRNY#OTC">ADRNY</a>) reported quarterly earnings of $0.74 per share. This is a 6.33 percent decrease over earnings of $0.79 per share from the same period last year. The company reported $24.84 billion in sales this quarter. This is a 0.24 percent increase over sales of $24.78 billion the same period last year.

Koninklijke Ahold Delhaiz Q4 Adj. EPS $0.74 Down From $0.79 YoY, Sales $24.84B Up From $24.78B YoY

With U.S. stock futures trading slightly lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) to report quarterly earnings at 93 cents per share on revenue of $97.19 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. CVS Health shares gained 1.3% to close at $55.00 on Tuesday.</li>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) reported better-than-expected earnings for its fourth quarter and named Bob Gold as its new CFO. The company also said it sees FY2025 adjusted earnings of $1.10 to $1.30 per share on sales of $1.950 billion to $2.000 billion. Pitney Bowes shares jumped 9.8% to $9.60 in the after-hours trading session.</li>
<li>Analysts are expecting The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) to post quarterly earnings at 78 cents per share on revenue of $6.66 billion. The company will release earnings before the markets open. Kraft Heinz shares gained 0.2% to $29.65 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) reported worse-than-expected earnings for its fourth quarter and issued weak revenue guidance for the first quarter. The company said it sees first-quarter sales of $575.000 million to $590.000 million versus market estimates of $600.20 million. Zillow shares dipped 6.3% to $80.90 in the after-hours trading session.</li>
<li>Analysts expect Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) to post quarterly earnings at 91 cents per share on revenue of $13.87 billion after the closing bell. Cisco shares gained 0.1% to $62.49 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday

Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) announced that it has captured 12% of the U.S. e-commerce market share, expanding from its origins as a platform for small businesses.
What Happened: During its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43636620/shopifys-revenue-growth-outpaces-estimates-but-paypal-related-margin-impact-raises-questions-analyst">fourth quarter of 2024 earnings call</a>, the e-commerce giant revealed this milestone alongside a strategic push into enterprise-level commerce. As of June 2022, Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) dominated the U.S. e-commerce market with a 37.8% share, according <a href="https://www.statista.com/statistics/274255/market-share-of-the-leading-retailers-in-us-e-commerce/">to</a> Statista.
The company&#8217;s enterprise momentum has accelerated notably, with major brands including Reebok, Champion, Warner Music Group, and David&#8217;s Bridal joining the platform in the fourth quarter. Shopify President Harley Finkelstein highlighted a dramatic shift in enterprise interest, noting that &#8220;pretty much every retailer and every major brand on the planet is now looking to Shopify,&#8221; a marked change from just 12 months ago.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43647866/robinhood-director-baiju-bhatt-sells-5-million-in-options-ahead-of-q4-earnings">Robinhood Director Baiju Bhatt Sells $5 Million In Options Ahead Of Q4 Earnings</a>
Why It Matters: A key competitive advantage has emerged in Shopify&#8217;s implementation speed, with the platform capable of launching major brands in three months compared to the traditional 12-18-month timeline. This efficiency is complemented by a significant cost advantage, with Ernst &amp; Young reporting that Shopify&#8217;s architecture enables a 22% lower cost of ownership for enterprise retailers.
The company has strengthened its enterprise position through strategic partnerships with major system integrators including WPP, EY, IBM, and Oracle, who are building dedicated Shopify implementation practices. 
Shopify has a <a href="https://www.benzinga.com/quote/SHOP/analyst-ratings">consensus price target</a> of $100.69 from 35 analysts, with a high of $175 and a low of $65. Recent ratings from Citigroup, RBC Capital, and Wedbush average $143.33, implying a 16.11% upside.
<figure class="wp-block-image aligncenter size-large is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12012129/Screenshot-2025-02-12-at-11.50.48%E2%80%AFAM-1024x385.png" alt="" class="wp-image-777834" style="width:785px;height:auto" /></figure>
Price Action: Shopify stock closed at $123.59 on Tuesday, up 3.08%. After-hours, it dipped 0.11% to $123.45. Year to date, shares have gained 14.94%, rising 38.68% over the past year, according to <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

AMZN

SHOP

Shopify Secures 12% Of US E-Commerce Pie As Reebok, Champion, And Warner Music Join Platform

SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) reported quarterly losses of $(0.83) per share. This is a 138.07 percent decrease over earnings of $2.18 per share from the same period last year. The company reported $12.03 billion in sales this quarter. This is a 0.16 percent increase over sales of $12.01 billion the same period last year.

SFTBF

SFTBY

SoftBank Group Q3 EPS $(0.83) Down From $2.18 YoY, Sales $12.03B Up From $12.01B YoY

Warner Bros Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) and Jinjiang International have unveiled plans to establish a &#8220;Harry Potter Studio Tour&#8221; in Shanghai. This venture is part of a broader renovation project, with the opening slated for 2027.
What Happened: Warner Bros and Chinese conglomerate Jinjiang International have decided to construct a &#8220;Harry Potter Studio Tour&#8221; in Shanghai, reported Reuters. The planned theme park will give visitors a glimpse into the making of the Harry Potter movies and recreate memorable scenes in an area spanning over 53,000 square meters. However, the project is yet to receive regulatory approval.
This will be the third &#8220;Harry Potter Studio Tour&#8221; by Warner Bros globally, joining the existing locations in London and Tokyo, but is likely to be nearly four times bigger than the London park inaugurated in 2012. 
Although foreign films account for only a small portion of China&#8217;s total box office due to strict quotas and a strong preference for local productions, the Harry Potter series remains hugely popular in the country.
The tour is designed to give visitors an immersive experience, highlighting the magic of filmmaking, the brilliant designs, and the unique creativity behind the Harry Potter films, while offering an in-depth exploration of the magical world of Harry Potter.
SEE ALSO: <a href="https://www.benzinga.com/general/entertainment/25/01/43017986/warner-bros-discovery-analyst-says-dtc-strength-wont-offset-joker-folie-a-deux-flop-nba-rights-concerns">Warner Bros. Discovery Analyst Says DTC Strength Won&#8217;t Offset &#8216;Joker: Folie A Deux&#8217; Flop, NBA Rights Concerns</a>
Why It Matters:&nbsp;This move comes in the wake of&nbsp;<a href="https://www.benzinga.com/24/12/42468724/warner-bros-discovery-restructures-with-focus-on-streaming-and-tv-divisions-stock-shoots-up">Warner Bros. Discovery&#8217;s restructuring plan</a>, approved in December 2024. The new corporate structure divided Warner Bros. Discovery into two distinct operating divisions: Global Linear Networks and Streaming &amp; Studios. 
The latter division, which includes film and entertainment studios, is responsible for managing its intellectual property portfolio. The upcoming &#8220;Harry Potter Studio Tour&#8221; in Shanghai is a part of this division aimed at leveraging the company&#8217;s intellectual property to expand its global footprint.
Warner Bros. has been growing the Harry Potter franchise beyond films, exploring ventures such as the Fantastic Beasts spin-off, theater productions, studio tours, video games, and a new TV series set to debut on Max in 2026.
As per a company filing in October, Warner Bros&#8217; Harry Potter studio tour near London surpassed £100 million (approximately $124 million) in profit for the year ended December 2022 while generating over 100 new jobs to meet the growing demand for the attraction.
READ MORE: <a href="https://www.benzinga.com/general/entertainment/25/02/43520895/disney-cuts-content-budget-by-1-billion-as-it-pushes-for-efficiency-house-of-mouse-says-too-early-to-revise-guidance-despite-earnings-beat">Disney Cuts Content Budget By $1 Billion As It Pushes For Efficiency: House Of Mouse Says Too Early To Revise Guidance Despite Earnings Beat</a>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Entertainment

Warner Bros Announces Shanghai Harry Potter Studio Tour—Set To Be Four Times Larger Than London's

As DoorDash Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) user base exploded to 42 million monthly active users with order frequency at an all-time high, its grocery and retail vertical saw stellar growth along with the aforementioned metrics in the <a href="https://www.benzinga.com/general/restaurants/25/02/43641832/doordash-shares-climb-after-solid-q4-results-total-orders-grew-19-gov-increased-21">fourth quarter</a>.
What Happened: DoorDash&#8217;s customers were ordering from all categories, explained the company CFO Ravi Inukonda during its earnings call. &#8220;We are the fastest growing in the U.S., we&#8217;ve gained share in new verticals through the year,&#8221; he said.
Emphasizing the grocery segment penetration Inukonda added &#8220;There are several countries where new verticals and grocery penetration in the international portfolio is actually higher than what we&#8217;re seeing in the U.S.&#8221;
DoorDash highlighted its current 42 million monthly active users are growing in double-digits and the record order frequency at an &#8220;all-time high&#8221; indicates strong user engagement and platform stickiness. 
Furthermore, talking about DashPass subscriptions co-founder and CEO, Tony Xu said that they have over 100 million customers, who order with the brand annually and its DashPass and Wolt+ subscribers were only in &#8220;the tens of millions.&#8221;
&#8220;So we have a large fraction of our customer base within our own ecosystem that are not subscribers. So that&#8217;s the first thing we have to go and solve,&#8221; added Xu.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43616409/warren-buffetts-berkshire-hathaway-loads-up-on-sirius-xm-amid-price-target-cuts-company-pays-dividend-but-better-off-in-t-bills-says-expert">Warren Buffett&#8217;s Berkshire Hathaway Loads Up On Sirius XM Amid Price Target Cuts: Company Pays Dividend ‘But Better Off In T-Bills,&#8217; Says Expert </a>
Why It Matters: DoorDash&#8217;s fourth-quarter earnings per share met <a href="https://www.benzinga.com/general/restaurants/25/02/43641832/doordash-shares-climb-after-solid-q4-results-total-orders-grew-19-gov-increased-21">expectations</a> at $0.33, while revenue beat estimates at $2.87 billion. Total orders rose to 685 million, up 19% year-over-year. Marketplace GOV, which stands total dollar value of orders completed in the company&#8217;s marketplaces, increased by 21% to $21.3 billion.
The company anticipates its adjusted EBITDA, as a percentage of Marketplace GOV, will grow sequentially throughout the year, increasing from the first quarter to the second quarter, and again from the second quarter to the third quarter. CFO added that DoorDash was &#8220;very confident with the outlook for the full-year.&#8221;
Price Action: The shares rose by 0.24% to $193.09 apiece on Tuesday and advanced by 5.71% in after-hours, whereas the exchange-traded fun tracking Nasdaq 100 index, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.24%.
DASH shares have gained 13.15% on a year-to-date basis, whereas it was up by 63.03% over the last year.
The average price target among 33 <a href="https://www.benzinga.com/quote/DASH/analyst-ratings">analysts tracked by Benzinga</a> is $180.94 with a ‘buy' rating. The estimates range from $115 to $225 apiece. Recent ratings from Benchmark, JMP Securities, and UBS suggest a $206.67 target, implying a potential upside of 1.25%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/DASH/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="385" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12014648/DoorDash-ANR-1024x385.png" alt="" class="wp-image-777866" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12014648/DoorDash-ANR-1024x385.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12014648/DoorDash-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12014648/DoorDash-ANR-768x289.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12014648/DoorDash-ANR.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43647586/coca-cola-won-overall-share-from-pepsi-maaza-crosses-1-billion-milestone-analyst-says-never-seen-fundamentals-this-good-amid-strong-2025-outlook">Coca-Cola &#8216;Won Overall Share&#8217; From Pepsi: Analyst Says &#8216;Never Seen Fundamentals This Good,&#8217; Amid Strong 2025 Outlook </a></li>
</ul>
Photo courtesy: Shutterstock

Earnings Beats

Market Summary

Broad U.S. Equity ETFs

ETFs

General

DASH

DoorDash Surges To 42M Monthly Users As Grocery And Retail Sales Soar Amid Record Order Frequency

The Company's revenues for the year ended December 31, 2024 are expected to increase by approximately 45% and are expected to amount to approximately $900,000, compared to revenues of approximately $620,000 in the year ended December 31, 2023.
As of December 31, 2024, the Company had cash and cash equivalents of approximately $4.2 million, compared to approximately $7.4 million on December 31, 2023.

PRZO

Reported Earlier, ParaZero Announces Preliminary 2024 Results: Revenue Jumps 45% YoY To $900K, Cash Reserves At $4.2M

<ul>
<li>The venture between Ericsson and global telecom operators is announcing a strategic partnership with Infobip to expand the reach of advanced network APIs.</li>
</ul>

ERIC

Ericsson-Backed Aduna Partners With Infobip To Empower Developers With Advanced Network APIs

MXCT

MaxCyte And TG Therapeutics Sign Strategic Platform License To Advance Autoimmune Cell Therapies

Broadridge enables Upvest to streamline shareholder interactions with enhanced transparency, further enabling the democratization and digitization of corporate governance

Broadridge Expands Partnership With Upvest To Streamline Proxy Voting And Shareholder Communication

INDV

Indivior Updates On SUBLOCADE Label Changes: FDA Approval Delayed Despite No Pending Concerns

Program expansion will increase collaboration with small and medium-sized businesses

Collins Aerospace Launches 2025 Edition Of 'Powered by Collins Initiative' At Aero India, Focusing On Deep Tech SMEs

H.C. Wainwright analyst Ed Arce initiated coverage of NewAmsterdam Pharma (NAMS) with a Buy rating and $48 price target NewAmsterdam is a late-stag...

NewAmsterdam Pharma initiated with a Buy at H.C. Wainwright

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Legend Biotech (LEGN – Research Report) and NewAmste...

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

American Air upgraded, Nordstrom downgraded: Wall Street's top analyst calls

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Boeing (BA) shares were under pressure...

Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz

Merck downgraded by Truist to hold over growth concerns

Annexon (ANNX) announced the appointment of William "BJ" Jones to its board of directors. He currently serves as chief commercial officer of NewAms...

Annexon appoints William Jones to board of directors

NewAmsterdam Pharma Company ( ($NAMS) ) has provided an announcement. NewAmsterdam Pharma reported significant achievements in 2024 with positive r...

NewAmsterdam Pharma Achieves Key Milestones in 2024

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NewAmsterdam Pharma Company (NAMS – Research Report)...

Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS), Illumina (ILMN) and RegenXBio (RGNX)

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on NAMS stock, giving a Buy rating on January 14. Roanna Ruiz has given hi...

Buy Recommendation for NewAmsterdam Pharma: Strong Potential of Obicetrapib Backed by Positive Phase 3 Trial Results and Market Positioning

RBC Capital analyst Leonid Timashev maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of...

RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

AMGN

AMTM

ANNX

ARQT

ARTV

AXSM

CTOR

CTXR

HSAI

ILMN

KULR

LEGN

MSTR

NAMS

NUVL

NVDA

RCKT

RGNX

RHHBY

RHHVF

SEAT

TLRY

TTWO

VCSA

WKSP

Press Releases

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia

Legal

NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Financing

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Health Care

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities

Comments

NewAmsterdam Pharma

Interés en corto

NewAmsterdam Pharma (NASDAQ:NAMS) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL